GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are designed to target the activity of NKT cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune system to homeostasis. NKT cells are innate-like T cells that share properties of both NK and T cells and are a functional link between the innate and adaptive immune responses. Type 1 invariant NKT (iNKT) cells play a critical role in propagating the injury, inflammatory response, and fibrosis observed in inflammatory and fibrotic indications. GRI Bio’s lead program, GRI-0621, is an inhibitor of iNKT cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis, a serious disease with significant unmet need. The Company is also developing a pipeline of novel type 2 NKT agonists for the treatment of systemic lupus erythematosus. Additionally, with a library of over 500 proprietary compounds, GRI Bio has the ability to fuel a growing pipeline.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 8954 Rio San Diego Drive,
- Industry
- Biotechnology
- Website
- http://www.gribio.com
- Keywords
- NKT cells, inflammation, hepatitis, autoimmunity, alcoholic liver disease, liver disease, fibrosis, 505(b)(2), Natural Killer T, drug development.
- HQ
- San Diego, CA
Gri Bio, Inc. Questions
Gri Bio, Inc.'s website is http://www.gribio.com
Gri Bio, Inc.'s LinkedIn profile is https://www.linkedin.com/company/gribio
Gri Bio, Inc. has
12 employees.
View email and phone details for 12
employees at Gri Bio, Inc..
Gri Bio, Inc.'s industry is
Biotechnology
Gri Bio, Inc.'s top competitors are
Ypo,
Marinus Pharma,
Inhibrx Biosciences, Inc.,
Biora Therapeutics,
Robin Hood Ventures,
Biomx (Nyse: Phge),
Vallon Pharmaceuticals,
Equillium, Inc.,
Sonnet Biotherapeutics,
Regencor Inc..
Gri Bio, Inc.'s categories are Biotechnology
Gri Bio, Inc.'s founding year is 2009
